Texas Instruments Appoints New CFO, Julie Knecht
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Source: NASDAQ.COM
Texas Instruments' stock fell 5.00% as it crossed below the 5-day SMA, reflecting broader market weakness with the Nasdaq-100 down 2.56% and the S&P 500 down 1.23%.
The company announced the appointment of Julie Knecht as the new Chief Financial Officer, effective August 1, 2026, succeeding Rafael Lizardi, who will retire after 25 years. Knecht's extensive experience at Texas Instruments, including her role as Chief Accounting Officer, is expected to ensure continuity in financial strategy and operational excellence. The upcoming second-quarter financial results announcement on July 22, 2026, is anticipated to provide further insights into the company's performance.
This leadership transition is seen as a strategic move to maintain stability and drive growth amid increasing demand for analog chips, which are crucial for AI data centers. Investors will be watching closely to see how Knecht's leadership influences the company's financial trajectory.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TXN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TXN
Wall Street analysts forecast TXN stock price to fall
20 Analyst Rating
10 Buy
5 Hold
5 Sell
Hold
Current: 305.370
Low
125.00
Averages
193.53
High
245.00
Current: 305.370
Low
125.00
Averages
193.53
High
245.00
About TXN
Texas Instruments Incorporated is engaged in the design and manufacture of semiconductors. The Company operates through two segments, which include Analog and Embedded Processing. Its Analog segment semiconductors are used to manage power in all electronic equipment by converting, distributing, storing, discharging, isolating, and measuring electrical energy. It consists of two products, which include Power and Signal Chain. The Analog segment includes product lines, such as Power and Signal Chain. Power includes products that help customers manage power in electronic systems. Signal Chain products include amplifiers, data converters, interface products, motor drives, clocks, logic, and sensing products. Its portfolio is designed to manage power requirements across different voltage levels. The Embedded Processing segment products are designed to handle specific tasks and can be optimized for various combinations of performance, power, and cost, depending on the application.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Analysis of High Dividend Stock Investment Opportunities
- Pfizer Overview: Pfizer (PFE) currently boasts a dividend yield of 6.7%, and despite an average annual loss of about 7% over the past three years, its stock price has risen 17% in the past year, indicating some recovery potential and reflecting market confidence in its future drug development.
- UPS Strategic Shift: United Parcel Service (UPS) offers a dividend yield of 7.7%, and although it has posted an average annual loss of 8.6% over the past three years, the company is shifting focus to higher-margin customer segments, which is expected to enhance long-term profitability despite a 2.3% decline in domestic revenue.
- ETF Investment Option: The Schwab U.S. Dividend Equity ETF (SCHD) recently yielded 3.25% and invests in approximately 100 dividend-paying companies, having risen nearly 20% year-to-date, providing investors with a mix of stable income and growth potential.
- Market Valuation Analysis: Pfizer and UPS have forward P/E ratios of 9.0 and 14.0, respectively, both below their five-year averages, indicating that the market has low growth expectations for these companies, potentially offering value investment opportunities for investors.
See More
Pfizer's Drug Pipeline Shows Promising Potential
- Pfizer's Dividend Appeal: Pfizer boasts a dividend yield of 6.7%, and despite an average annual loss of about 7% over the past three years, its stock has risen 17% in the past year, indicating market confidence in its future drug development.
- Rich Drug Pipeline: Pfizer is addressing patent expirations by continuously developing new drugs and acquiring promising candidates, a strategy that not only helps maintain revenue streams but could also lead to significant market share growth in the future.
- UPS Strategic Shift: UPS's recent decision to cut back on deliveries for Amazon in favor of higher-margin customers, such as small businesses and healthcare, has resulted in a 2.3% decline in overall domestic revenue, yet revenue per package grew by 6.5%, reflecting an improvement in profitability.
- ETF Investment Opportunity: The Schwab U.S. Dividend Equity ETF offers a yield of 3.25% and has risen nearly 20% year-to-date, providing investors with a solid mix of income and growth potential, making it a good choice for diversified investment.
See More
Recommended High-Yield ETF: Schwab U.S. Dividend Equity ETF
- Income and Growth Balance: The Schwab U.S. Dividend Equity ETF boasts a dividend yield of 3.25% and has risen 19% year-to-date in 2026, delivering slightly lower growth than the S&P 500 while providing nearly three times the dividend income, indicating a strong balance between income and growth.
- Expense Ratio Advantage: With an expense ratio of just 0.06%, investors pay only $6 for every $10,000 invested, making it competitive among similar products and enhancing net returns for investors.
- Robust Portfolio Composition: The ETF tracks the Dow Jones U.S. Dividend 100 Index, comprising 100 stocks with a history of at least 10 years of dividend payments, ensuring financial health among constituents and reducing the risk of dividend cuts due to financial troubles, thus enhancing long-term investment safety.
- Diversified Holdings Structure: The top ten holdings account for about 43% of the ETF, with 18% in consumer defensive stocks, 15% in energy, and 18% in healthcare, providing a diversified allocation that helps maintain stability and risk resistance in the event of a market pullback.
See More
Analysis of Schwab U.S. Dividend Equity ETF
- Dividend Yield Advantage: The Schwab U.S. Dividend Equity ETF boasts a dividend yield of 3.25%, approximately three times that of the S&P 500, indicating its stability during market fluctuations and appealing to income-seeking investors.
- Strong Performance: With a three-year average annual return of 15.09%, the ETF, while lower than the S&P 500's 22.44%, outperforms many other dividend-focused funds, demonstrating a solid balance between income and growth.
- Low Expense Ratio: The ETF's expense ratio stands at just 0.06%, meaning investors pay only $6 for every $10,000 invested, enhancing its cost-effectiveness and attractiveness for long-term investors.
- Diversified Portfolio: Tracking the Dow Jones U.S. Dividend 100 Index, the ETF includes 100 stocks with a minimum 10-year dividend payment history, with about 43% of its assets in the top 10 holdings, showcasing a strong allocation in defensive and growth sectors to adapt to future market volatility.
See More
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
Broadcom Shares Slide on Disappointing AI Chip Sales Guidance
- Stock Decline: Broadcom (NASDAQ:AVGO) closed at $385.73, down 7.92%, primarily due to investor disappointment over AI chip sales guidance and valuation concerns, reflecting a cautious market sentiment regarding the company's future growth prospects.
- Surge in Trading Volume: The company's trading volume reached 50.3 million shares, approximately 95% above its three-month average of 25.7 million shares, indicating a significant increase in market interest in Broadcom's stock despite the price drop.
- Performance vs. Expectations: Although Broadcom's Q2 earnings report showed revenue rising to $22.19 billion, with AI semiconductor revenue more than doubling and AI bookings exceeding $30 billion, management's decision not to raise long-term AI revenue targets led to diminished market confidence in future growth.
- Market Reaction: The pullback in Broadcom's stock price suggests that market expectations for its AI business may have been overly optimistic, with investors closely monitoring whether custom AI chip bookings can quickly convert to revenue to support the company's goal of over $100 billion in AI semiconductor revenue by fiscal 2027.
See More
Analysis of High Dividend Stock Investment Opportunities
- Pfizer Overview: Pfizer (PFE) currently boasts a dividend yield of 6.7%, and despite an average annual loss of about 7% over the past three years, its stock price has risen 17% in the past year, indicating some recovery potential and reflecting market confidence in its future drug development.
- UPS Strategic Shift: United Parcel Service (UPS) offers a dividend yield of 7.7%, and although it has posted an average annual loss of 8.6% over the past three years, the company is shifting focus to higher-margin customer segments, which is expected to enhance long-term profitability despite a 2.3% decline in domestic revenue.
- ETF Investment Option: The Schwab U.S. Dividend Equity ETF (SCHD) recently yielded 3.25% and invests in approximately 100 dividend-paying companies, having risen nearly 20% year-to-date, providing investors with a mix of stable income and growth potential.
- Market Valuation Analysis: Pfizer and UPS have forward P/E ratios of 9.0 and 14.0, respectively, both below their five-year averages, indicating that the market has low growth expectations for these companies, potentially offering value investment opportunities for investors.
See More
Pfizer's Drug Pipeline Shows Promising Potential
- Pfizer's Dividend Appeal: Pfizer boasts a dividend yield of 6.7%, and despite an average annual loss of about 7% over the past three years, its stock has risen 17% in the past year, indicating market confidence in its future drug development.
- Rich Drug Pipeline: Pfizer is addressing patent expirations by continuously developing new drugs and acquiring promising candidates, a strategy that not only helps maintain revenue streams but could also lead to significant market share growth in the future.
- UPS Strategic Shift: UPS's recent decision to cut back on deliveries for Amazon in favor of higher-margin customers, such as small businesses and healthcare, has resulted in a 2.3% decline in overall domestic revenue, yet revenue per package grew by 6.5%, reflecting an improvement in profitability.
- ETF Investment Opportunity: The Schwab U.S. Dividend Equity ETF offers a yield of 3.25% and has risen nearly 20% year-to-date, providing investors with a solid mix of income and growth potential, making it a good choice for diversified investment.
See More
Recommended High-Yield ETF: Schwab U.S. Dividend Equity ETF
- Income and Growth Balance: The Schwab U.S. Dividend Equity ETF boasts a dividend yield of 3.25% and has risen 19% year-to-date in 2026, delivering slightly lower growth than the S&P 500 while providing nearly three times the dividend income, indicating a strong balance between income and growth.
- Expense Ratio Advantage: With an expense ratio of just 0.06%, investors pay only $6 for every $10,000 invested, making it competitive among similar products and enhancing net returns for investors.
- Robust Portfolio Composition: The ETF tracks the Dow Jones U.S. Dividend 100 Index, comprising 100 stocks with a history of at least 10 years of dividend payments, ensuring financial health among constituents and reducing the risk of dividend cuts due to financial troubles, thus enhancing long-term investment safety.
- Diversified Holdings Structure: The top ten holdings account for about 43% of the ETF, with 18% in consumer defensive stocks, 15% in energy, and 18% in healthcare, providing a diversified allocation that helps maintain stability and risk resistance in the event of a market pullback.
See More
Analysis of Schwab U.S. Dividend Equity ETF
- Dividend Yield Advantage: The Schwab U.S. Dividend Equity ETF boasts a dividend yield of 3.25%, approximately three times that of the S&P 500, indicating its stability during market fluctuations and appealing to income-seeking investors.
- Strong Performance: With a three-year average annual return of 15.09%, the ETF, while lower than the S&P 500's 22.44%, outperforms many other dividend-focused funds, demonstrating a solid balance between income and growth.
- Low Expense Ratio: The ETF's expense ratio stands at just 0.06%, meaning investors pay only $6 for every $10,000 invested, enhancing its cost-effectiveness and attractiveness for long-term investors.
- Diversified Portfolio: Tracking the Dow Jones U.S. Dividend 100 Index, the ETF includes 100 stocks with a minimum 10-year dividend payment history, with about 43% of its assets in the top 10 holdings, showcasing a strong allocation in defensive and growth sectors to adapt to future market volatility.
See More
US Stocks Plunge Sharply, Tech Sector Under Pressure
- Market Decline: The S&P 500 fell 2.64% and the Nasdaq 100 dropped 4.77%, indicating a significant loss of investor confidence in tech stocks, particularly as AI infrastructure and semiconductor companies faced sell-offs, which could impact future investment strategies.
- Strong Employment Data: US nonfarm payrolls rose by 172,000 in May, significantly exceeding expectations of 88,000, while the unemployment rate held steady at 4.3%, potentially prompting the Fed to consider a rate hike at the upcoming meeting, thereby affecting market liquidity and investor sentiment.
- Rising Bond Yields: The 10-year Treasury yield climbed to 4.55%, a two-week high, reflecting heightened expectations for future rate hikes, which may lead to capital outflows from the stock market, further exacerbating market volatility.
- Tech Stock Retreat: Following Broadcom's disappointing chip sales outlook, Marvell and Micron stocks plummeted over 16% and 13%, respectively, suggesting that the market's overly optimistic sentiment towards tech stocks may be correcting, impacting investor confidence.
See More
Broadcom Shares Slide on Disappointing AI Chip Sales Guidance
- Stock Decline: Broadcom (NASDAQ:AVGO) closed at $385.73, down 7.92%, primarily due to investor disappointment over AI chip sales guidance and valuation concerns, reflecting a cautious market sentiment regarding the company's future growth prospects.
- Surge in Trading Volume: The company's trading volume reached 50.3 million shares, approximately 95% above its three-month average of 25.7 million shares, indicating a significant increase in market interest in Broadcom's stock despite the price drop.
- Performance vs. Expectations: Although Broadcom's Q2 earnings report showed revenue rising to $22.19 billion, with AI semiconductor revenue more than doubling and AI bookings exceeding $30 billion, management's decision not to raise long-term AI revenue targets led to diminished market confidence in future growth.
- Market Reaction: The pullback in Broadcom's stock price suggests that market expectations for its AI business may have been overly optimistic, with investors closely monitoring whether custom AI chip bookings can quickly convert to revenue to support the company's goal of over $100 billion in AI semiconductor revenue by fiscal 2027.
See More
